摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-溴-3,6-二氢-2H-吡喃 | 24265-23-4

中文名称
4-溴-3,6-二氢-2H-吡喃
中文别名
——
英文名称
4-bromo-3,6-dihydro-2H-pyran
英文别名
——
4-溴-3,6-二氢-2H-吡喃化学式
CAS
24265-23-4
化学式
C5H7BrO
mdl
——
分子量
163.014
InChiKey
WSVCDRYCXKRMRC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    184.5±40.0 °C(Predicted)
  • 密度:
    1.580±0.06 g/cm3(Predicted)
  • 溶解度:
    可溶于氯仿(少许)

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    7
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2932999099

SDS

SDS:dac9737730a0713b7f5f97152f8c61f0
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Bromo-3,6-dihydro-2H-pyran
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-Bromo-3,6-dihydro-2H-pyran
CAS number: 24265-23-4

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, under −20◦C.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C5H7BrO
Molecular weight: 163.0

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

化学性质 4-溴-3,6-二氢-2H-吡喃是一种含有六元环的有机化合物,在4号位有一个溴原子取代,并且3号和6号位的碳原子各有一个氢原子,使这些位置的碳原子处于饱和状态。这种结构通常赋予该化合物较好的有机溶剂溶解性,由于溴原子的存在,它可能在化学反应中表现出一定的活性,例如参与取代或消除反应。

外观 4-溴-3,6-二氢-2H-吡喃为淡黄色油状液体。

用途 4-溴-3,6-二氢-2H-吡喃是一种用于有机合成及科研实验的喃类衍生物

合成方法 将四氢吡喃-4-酮(10.0克,0.1摩尔)、对甲基甲苯(18.6克,0.1摩尔)和乙醇120 mL混合后,加热回流反应。反应完成后蒸发掉溶剂,直接加入DBU(22.8g,0.15摩尔)和150毫升二氯甲烷中,然后滴加NBS(26.7克,0.15mol)溶解在40 mL二氯甲烷溶液中。反应完成后,通过加入10%盐酸调节pH至4-5,分离有机层,在常压下蒸发溶剂,再通过加入20 mL环丁砜进行真空蒸馏,最终获得12.2 g浅黄色液体:4-溴-3,6-二氢-2H-吡喃。气相色谱分析显示纯度为98.4%,产率为75%。

反应信息

点击查看最新优质反应信息

文献信息

  • HETEROCYCLICALLY SUBSTITUTED ARYL COMPOUNDS AS HIF INHIBITORS
    申请人:Härter Michael
    公开号:US20130196964A1
    公开(公告)日:2013-08-01
    The present application relates to novel aryl compounds with heterocyclic substituents, processes for their preparation, their use for treatment and/or prevention of diseases and their use for the preparation of medicaments for treatment and/or prevention of diseases, in particular for treatment and/or prevention of hyperproliferative and angiogenic diseases and those diseases which arise from metabolic adaptation to hypoxic states. Such treatments can be carried out as monotherapy or also in combination with other medicaments or further therapeutic measures.
    本申请涉及具有杂环取代基的新型芳基化合物,其制备方法,它们用于治疗和/或预防疾病以及用于制备治疗和/或预防疾病的药物,特别是用于治疗和/或预防过度增殖和血管生成性疾病以及那些由于代谢适应缺氧状态而引起的疾病。这种治疗可以作为单独治疗进行,也可以与其他药物或进一步治疗措施结合使用。
  • Rhodium-Catalyzed Enantioselective Intramolecular Hydroacylation of Trisubstituted Alkenes
    作者:Kirsten F. Johnson、Eugene A. Schneider、Brian P. Schumacher、Arkady Ellern、Joseph D. Scanlon、Levi M. Stanley
    DOI:10.1002/chem.201603880
    日期:2016.10.24
    We report the first examples of transition metal‐catalyzed enantioselective alkene hydroacylations with 1,1,2‐trisubstituted alkenes. DFT and mechanistic studies are consistent with a reaction pathway for these rhodium‐catalyzed processes including intramolecular alkene hydroacylation and α‐epimerization to generate highly enantioenriched, polycyclic architectures. This reaction sequence enables the
    我们报告了第一个用1,1,2-三取代烯烃进行过渡属催化的对映选择性烯烃加氢酰化的例子。DFT和机理研究与这些催化过程的反应途径一致,这些过程包括分子内烯烃加氢酰化和α-表异构化以生成高度对映体富集的多环结构。该反应顺序使2-(环己-1-烯-1-基)苯甲醛的加氢酰化,以形成六氢-9- ħ-9-酮在中度到高的产率(68-91%)与高对映选择性(高达99%ee)和非对映选择性(通常> 20:1)。
  • 含杂原子环己烯卤代物的制备方法
    申请人:蚌埠产品质量监督检验研究院
    公开号:CN110563696B
    公开(公告)日:2022-05-03
    本发明公开了含杂原子环己烯卤代物的制备方法,属于精细化工中间体合成领域。以含杂原子环己酮为原料,在卤代试剂中生成偕二卤代物或烯基卤代物为主,在有机碱中加入添加剂后,脱卤化氢生成含杂原子环己烯卤代物。此方法工艺简单,避免了传统方法中混合物纯化的操作,产物得到了充分利用。在偕二代物类似消除条件下,通过加入添加剂克服了偕二代物消除难点,通过不同碱的位阻来达到控制区域选择性的目的。
  • [EN] HETEROARYL COMPOUNDS FOR KINASE INHIBITION<br/>[FR] COMPOSÉS HÉTÉROARYLE D'INHIBITION DE LA KINASE
    申请人:ARIAD PHARMA INC
    公开号:WO2015195228A1
    公开(公告)日:2015-12-23
    Compounds and pharmaceutical compositions that modulate kinase activity, including mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant EGFRand mutant HER2 activity, are described herein.
    调节激酶活性的化合物和药物组合物,包括突变的EGFR和突变的HER2激酶活性,以及与激酶活性相关的疾病和病况的治疗方法、化合物、药物组合物,包括突变的EGFR和突变的HER2活性,均在本文中描述。
  • A Modular Approach to the Synthesis of <i>gem</i>-Disubstituted Cyclopropanes
    作者:Michael R. Harris、Hanna M. Wisniewska、Wenhua Jiao、Xiaochun Wang、James N. Bradow
    DOI:10.1021/acs.orglett.8b00899
    日期:2018.5.18
    Pd-catalyzed Suzuki–Miyaura coupling reaction of geminal bis(boryl)cyclopropanes has been developed. The reaction offers a highly modular approach to the synthesis of tertiary cyclopropylboronic esters. The resulting boronic esters may be further functionalized to afford a range of gem-disubstituted cyclopropanes, which represent an important structural motif in the pharmaceutical industry. Sequential Suzuki–Miyaura
    已经开发了双双(基)环丙烷的非对映选择性,Pd催化的Suzuki-Miyaura偶联反应。该反应为叔环丙基硼酸酯的合成提供了一种高度模块化的方法。所得的硼酸酯可以进一步官能化以提供一定范围的宝石-二取代的环丙烷,其代表了制药工业中的重要结构基序。还报道了宝石-双(基)环丙烷的顺序Suzuki-Miyaura交叉偶联反应。偶联方案与多种官能化的芳基和杂芳基化物兼容。
查看更多

同类化合物

(2R)-2,6-二羟基-5-[(E)-丙-1-烯基]-1,2-二氢吡喃并[3,2-b]吡咯-3,7-二酮 黄绿青霉素 麦芽醇 麦芽酚铁 马索亚内酯 香豆酸 香豆灵酸甲酯 香叶吡喃 顺式-1-(3-呋喃基)-1,7,8,8a-四氢-5,8a-二甲基-3H-2-苯并吡喃-3-酮 靠曼酸乙酯; 4-吡喃酮-2-羧酸乙酯 靠曼酸 镭杂9蛋白质 铝3-羟基-2-甲基-4-吡喃酮 钠[(1E,7E,9E,11E)-6-羟基-1-(3-羟基-6-氧代-2,3-二氢吡喃-2-基)-5-甲基十七碳-1,7,9,11-四烯-4-基]硫酸盐 避虫酮 辛伐他汀杂质C 褐鸡蛋花素 脱氢乙酸缩氨基硫脲 脱氢乙酸 罌粟酸 维达列汀 福司曲星 福司曲星 磷内酯霉素F 磷内酯霉素E 磷内酯霉素D 磷内酯霉素A 白屈菜酸 甲基6-甲氧基-2-甲基-5-氧代四氢-2H-吡喃-2-羧酸酯 甲基6-氧杂双环[3.1.0]己烷-1-羧酸酯 甲基4-氧代-4H-吡喃-3-羧酸酯 甲基4,6-二-O-乙酰基-2,3-二脱氧己-2-烯基吡喃糖苷 甲基2H-吡喃-5-羧酸酯 甲基2-乙氧基-6-甲基-3,4-二氢-2H-吡喃-4-羧酸酯 甲基2-乙氧基-4-氧代-3,4-二氢-2H-吡喃-5-羧酸酯 甲基2-乙氧基-3-甲基-4-氧代-3,4-二氢-2H-吡喃-5-羧酸酯 甲基(4S)-2-氧代-4-[(2E)-1-氧代-2-丁烯-2-基]-3,4-二氢-2H-吡喃-5-羧酸酯 甲基(2S,5R)-5-甲氧基-3-硝基-2,5-二氢-2-呋喃羧酸酯 甲基(2S)-4-甲基-3,6-二氢-2H-吡喃-2-羧酸酯 甲基(2R)-四氢-2H-吡喃-2-羧酸酯 环庚三烯并[b]吡喃-2(5H)-酮,9-(3-丁烯基)-3-(环丙基苯基甲基)-6,7,8,9-四氢-4-羟基- 环吡酮杂质B 焦袂康酸O-甲基醚 沉香四醇 氨甲酸,[3-[(苯基甲基)氨基]三环[3.3.1.13,7]癸-1-基]-,1,1-二甲基乙基酯(9CI) 毛子草酮 棒曲霉素-13C3 棒曲霉素 木菌素 木糖酸二钠盐